EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 151 filers reported holding EPIZYME INC in Q3 2020. The put-call ratio across all filers is 2.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,582,000 | -19.8% | 181,600 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $1,972,000 | -18.3% | 181,600 | -10.2% | 0.00% | 0.0% |
Q3 2020 | $2,413,000 | -23.9% | 202,239 | +2.5% | 0.00% | -33.3% |
Q2 2020 | $3,169,000 | +17.4% | 197,339 | +13.4% | 0.00% | 0.0% |
Q1 2020 | $2,700,000 | -57.0% | 174,092 | -31.8% | 0.00% | -50.0% |
Q4 2019 | $6,284,000 | +125.2% | 255,432 | -5.6% | 0.01% | +100.0% |
Q3 2019 | $2,790,000 | -3.5% | 270,445 | +17.4% | 0.00% | 0.0% |
Q2 2019 | $2,891,000 | +0.3% | 230,390 | -1.0% | 0.00% | -25.0% |
Q1 2019 | $2,882,000 | +270.0% | 232,600 | +83.9% | 0.00% | +300.0% |
Q4 2018 | $779,000 | -29.2% | 126,500 | +21.9% | 0.00% | 0.0% |
Q3 2018 | $1,100,000 | -28.2% | 103,800 | -8.1% | 0.00% | -50.0% |
Q2 2018 | $1,531,000 | -36.3% | 113,000 | -16.6% | 0.00% | -33.3% |
Q1 2018 | $2,405,000 | +41.4% | 135,500 | 0.0% | 0.00% | +50.0% |
Q4 2017 | $1,701,000 | -34.1% | 135,500 | 0.0% | 0.00% | -50.0% |
Q3 2017 | $2,581,000 | +26.1% | 135,500 | 0.0% | 0.00% | +33.3% |
Q2 2017 | $2,046,000 | -10.0% | 135,500 | +2.2% | 0.00% | -25.0% |
Q1 2017 | $2,274,000 | +35.8% | 132,600 | -4.2% | 0.00% | +33.3% |
Q4 2016 | $1,675,000 | +17.1% | 138,400 | -4.8% | 0.00% | +50.0% |
Q3 2016 | $1,431,000 | -10.1% | 145,400 | -6.4% | 0.00% | -33.3% |
Q2 2016 | $1,591,000 | -18.1% | 155,400 | -3.1% | 0.00% | 0.0% |
Q1 2016 | $1,943,000 | -28.6% | 160,300 | -5.7% | 0.00% | -25.0% |
Q4 2015 | $2,723,000 | +33937.5% | 170,000 | +84900.0% | 0.00% | – |
Q3 2013 | $8,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |